Ground Breaking Product Set to Change the Electronic Cigarette Market

Whilst the formulation and extraction is secret the main active ingredient is derived from a herb known as Sceletium Tortousum or Kanna, protected under the Nagoya Biodiversity Protocol of the Convention of Biodiversity. It is also protected by the Biodiversity Act of South Africa. “The state of the art patented extraction process is able to maximise the yield and consistency of the alkaloids to the highest concentrations done to date commercially, without requiring fermentation, heat or chemical intervention,” said Roy Henderson, MD of RWH.

All production comes with a verifiable MSDS, Certificate of Analysis and regular High Performance Liquid Chromatography tests are undertaken to confirm purity and alkaloid content. Production abides by cGMP (current Good Manufacturing Processes) to meet international requirements.

What is it so special? Firstly, the production process is very cost efficient and can compete on price with a comparable quality e-juice in the market. Secondly, the product provides a safe “experiential” effect, very similar to that of nicotine. Thirdly, Sceletium is known not to be addictive or hallucinogenic.

The main cause of the concern of e-cigs is the nicotine content and the fact that many consider this to be a gateway to cigarette smoking. The product is reliant on the synergistic effect of the eleven alkaloids found in Sceletium. Nicotine acts as a stimulant to the neurotransmitters dopamine (motor control, motivation, arousal, cognition, and reward) and serotonin (well-being and happiness) but through dependency ultimately suppresses serotonin release. The Sceletium alkaloids stimulate all of these neurotransmitters and are regarded as one of the most potent selective serotonin reuptake inhibitors (SSRI).

“The product will be distributed under the registered trademark name of Alto Kanna Juice (or K-Juice) and we are now seeking partners to take it above the line. In all likelihood this product will be looked at as a direct competitor to nicotine or as a product that mimics nicotine and we will need ensure that the message to be put across dispels this notion,” said Tony Pass, the product innovator. “It is simply another stimulatory substance with a long heritage, almost forgotten through the passage of time. After all, Sceletium has been chewed or smoked by the San and Koi tribes of Africa possibly as long as 4,000 years ago, and at one stage was used as currency due to its rareness and effects. Sceletium is a unique plant and has been used as a health supplement in Europe since the mid-17th century when it was introduced into Holland by the Dutch Cape colonists.” 

The manufacturers look at Sceletium in the K-juice form as a safe alternative to smoking or vaping nicotine. “Granted we see the e-cig devices as the perfect delivery system which is modern, sleek and becoming a very fashionable statement particularly amongst celebrities, often a precursor to future trends and demand. Naturally we see the existing smokers in the EU and the USA as our target market and we will soon be in a position seek major distributors, either the big tobacco companies or as an opportunity for pharmaceutical companies to get a foothold in a 'vaping' market that is severely denting their nicotine based smoking cessation products.

"Our best guess is that Big Tobacco who knows the market inside out would be the forerunners,” said Tony Pass. “We know that some work is still to be done, in particular the marrying of the K-Juice to the right electronic device to give it its own identity and this is where the innovation departments of the tobacco or pharma companies could play a leading role,” he said.

“We do not make any health claims and see no reason why the restrictions placed on nicotine based substances are applicable as the products themselves have little in common in this regard,” Tony Pass concluded.

anthony michael pass
virtual tobacco company
+44(0)1242870134